The legacy of Viagra and its parent , copyright, presents a complex picture for cautious investors. While the iconic drug initially fueled enormous revenues , its patent has lapsed , leading to generic options flooding the landscape . This decline in cost presents a significant challenge for copyright and any company considering a significant posit